Related Experiment Video
Updated: Feb 14, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Body fluid identification using a targeted mRNA massively parallel sequencing approach - results of a
S Ingold1, G Dørum1, E Hanson2
1Zurich Institute of Forensic Medicine, University of Zurich, Switzerland.
Abstract:
In a previous study we presented an assay for targeted mRNA sequencing for the identification of human body fluids, optimised for the Illumina MiSeq/FGx MPS platform. This assay, together with an additional in-house designed assay for the Ion Torrent PGM/S5 platform, was the basis for a collaborative exercise within 17 EUROFORGEN and EDNAP laboratories, in order to test the efficacy of targeted mRNA sequencing to identify body fluids. The task was to analyse the supplied dried body fluid stains and, optionally, participants' own bona fide or mock casework samples of human origin, according to specified protocols. The provided primer pools for the Illumina MiSeq/FGx and the Ion Torrent PGM/S5 platforms included 33 and 29 body fluid specific targets, respectively, to identify blood, saliva, semen, vaginal secretion, menstrual blood and skin. The results demonstrated moderate to high count values in the body fluid or tissue of interest with little to no counts in non-target body fluids. There was some inter-laboratory variability in read counts, but overall the results of the laboratories were comparable in that highly expressed markers showed high read counts and less expressed markers showed lower counts. We performed a partial least squares (PLS) analysis on the data, where blood, menstrual blood, saliva and semen markers and samples clustered well. The results of this collaborative mRNA massively parallel sequencing (MPS) exercise support targeted mRNA sequencing as a reliable body fluid identification method that could be added to the repertoire of forensic MPS panels.
Insights
Targeted mRNA sequencing effectively identifies human body fluids like blood and semen. This forensic massively parallel sequencing (MPS) method shows reliable results across multiple laboratories.
Area of Science:
- Forensic Science
- Molecular Biology
- Genomics
Background:
- Previous research developed targeted mRNA sequencing assays for human body fluid identification.
- Assays were optimized for Illumina MiSeq/FGx and Ion Torrent PGM/S5 platforms.
Purpose of the Study:
- To evaluate the efficacy of targeted mRNA sequencing for identifying human body fluids.
- To assess inter-laboratory reproducibility and reliability of the method.
Main Methods:
- A collaborative exercise involving 17 laboratories using provided dried body fluid stains.
- Analysis of 33 (Illumina) and 29 (Ion Torrent) body fluid-specific mRNA targets.
- Partial least squares (PLS) analysis for data interpretation.
Main Results:
- Moderate to high mRNA read counts were observed for target body fluids, with minimal counts for non-targets.
- Results showed good comparability across laboratories, with marker expression correlating to read counts.
- PLS analysis demonstrated clear clustering for blood, menstrual blood, saliva, and semen samples.
Conclusions:
- Targeted mRNA sequencing is a reliable method for forensic body fluid identification.
- The method shows potential for inclusion in forensic massively parallel sequencing (MPS) panels.
- Collaborative exercises confirm the robustness and applicability of mRNA sequencing in forensic settings.
Related Concept Videos
Composition of Body Fluids
Regulated mRNA Transport
Body Water Content and Fluid Compartments
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Pharmacogenomics: Identification of New Drug Targets
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability

